Literature DB >> 8782822

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.

D Sakamuro1, K J Elliott, R Wechsler-Reya, G C Prendergast.   

Abstract

BIN1 is a novel protein that interacts with the functionally critical Myc box regions at the N terminus of the MYC oncoprotein. BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control. Consistent with this likelihood, BIN1 inhibited malignant cell transformation by MYC. Although BIN1 is expressed in many normal cells, its levels were greatly reduced or undetectable in 14/27 carcinoma cell lines and 3/6 primary breast tumours. Deficits were functionally significant because ectopic expression of BIN1 inhibited the growth of tumour cells lacking endogenous message. We conclude that BIN1 is an MYC-interacting protein with features of a tumour suppressor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782822     DOI: 10.1038/ng0996-69

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  113 in total

Review 1.  Genetics of dementia.

Authors:  Henry L Paulson; Indu Igo
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Bin1: a new player in IBD barrier dysfunction.

Authors:  Hyunji Ryu; Daniela Posca; Terrence Barrett
Journal:  Dig Dis Sci       Date:  2012-05-30       Impact factor: 3.199

3.  BAR proteins in cancer and blood disorders.

Authors:  Yolande Chen; Jorie Aardema; Ashish Misra; Seth J Corey
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  A two-hybrid system for transactivator bait proteins.

Authors:  M Hirst; C Ho; L Sabourin; M Rudnicki; L Penn; I Sadowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma.

Authors:  Ke Pan; Xiao-ting Liang; Hua-kun Zhang; Jing-jing Zhao; Dan-dan Wang; Jian-jun Li; Qizhou Lian; Alfred E Chang; Qiao Li; Jian-chuan Xia
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

6.  Characterization of the yeast amphiphysins Rvs161p and Rvs167p reveals roles for the Rvs heterodimer in vivo.

Authors:  Helena Friesen; Christine Humphries; Yuen Ho; Oliver Schub; Karen Colwill; Brenda Andrews
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

7.  Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis.

Authors:  P Wigge; K Köhler; Y Vallis; C A Doyle; D Owen; S P Hunt; H T McMahon
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

8.  BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.

Authors:  J Wang; Y Jia; S Zhao; X Zhang; X Wang; X Han; Y Wang; M Ma; J Shi; L Liu
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

9.  Molecular cloning, expression and chromosomal localization of mouse MM-1.

Authors:  Tetsuya Inazu; Zaw Myint; Asato Kuroiwa; Yoichi Matsuda; Tamio Noguchi
Journal:  Mol Biol Rep       Date:  2005-12       Impact factor: 2.316

10.  Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.

Authors:  Thomas Gonatopoulos-Pournatzis; Michael Aregger; Kevin R Brown; Shaghayegh Farhangmehr; Ulrich Braunschweig; Henry N Ward; Kevin C H Ha; Alexander Weiss; Maximilian Billmann; Tanja Durbic; Chad L Myers; Benjamin J Blencowe; Jason Moffat
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.